Health outcomes in type 2 diabetes

International Journal of Clinical Practice, Supplement

Volumn , Issue 113, 2000, Pages 46-53

  Reddy, S S K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C;

BLOOD PRESSURE MONITORING; DECISION MAKING; DYSLIPIDEMIA; FOOT ULCER; HEALTH CARE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE; RETINOPATHY; REVIEW; SOCIAL ASPECT;

DIABETES MELLITUS, TYPE 2; HEALTH CARE RATIONING; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 0033645863     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Long-term health care outcomes in diabetes: Economic and political implications
2. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature
3. Quality of life and diabetes
4. Symptoms and well-being in relation to glycemic control in type II diabetes
5. Determinants of the quality of life of patients with diabetes under intensified insulin therapy
6. Diabetes care in Germany: New roles for professionals and patients
7. Quality of life assessment in diabetes research: Interpreting the magnitude and meaning of treatment effects
8. Connecting value and costs: Whom do we ask and what do we ask them?
9. On the elicitation of preferences for alternative therapies
10. A critical review of priority setting in the health sector: The methodology of the 1993 World Development Report
11. The cost effectiveness of preference based treatment allocation: The case of hysterectomy versus endometrial resection in the treatment of menorrhagia
12. Discounting life-years: Whither time preference?
13. The measurement of individual utility and social welfare
14. When do health care decisions discriminate against persons with disabilities?
15. Psychosocial assessment of organ transplant candidates and the Americans with Disabilities Act
16. Ethical assumptions and ambiguities in the Americans with Disabilities Act
17. Ambiguities and irresolvable tensions in the ADA
18. Understanding DALYs
19. Model of complications of NIDDM. II Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
20. The cost-effectiveness for intensive therapy for diabetes mellitus
21. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
22. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients
23. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
24. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy